Oncogenic potential of a dominant negative mutant of interferon regulatory factor 3.
about
HnRNP A1/A2 and SF2/ASF regulate alternative splicing of interferon regulatory factor-3 and affect immunomodulatory functions in human non-small cell lung cancer cellsMammary serine protease inhibitor (Maspin) binds directly to interferon regulatory factor 6: identification of a novel serpin partnershipDown-regulated GATA-1 up-regulates interferon regulatory factor 3 in lung adenocarcinoma.Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancerIRF6 in development and disease: a mediator of quiescence and differentiation.Translational control plays a prominent role in the hepatocytic differentiation of HepaRG liver progenitor cells.The characterization of two novel IRF-3 transcripts starting from intron 2 of the wild type of IRF-3.Manipulation of the toll-like receptor 7 signaling pathway by Epstein-Barr virus.Kaposi's sarcoma-associated herpesvirus-encoded vIRF-3 stimulates the transcriptional activity of cellular IRF-3 and IRF-7.The IRF family of transcription factors: Inception, impact and implications in oncogenesis.Characterization of a novel isoform of the human ORMDL3 gene.Up-regulation of IRF-3 expression through GATA-1 acetylation by histone deacetylase inhibitor in lung adenocarcinoma A549 cells.Differential expression patterns of IRF3 and IRF7 in pediatric lymphoid disorders.IRF-3 gene polymorphisms are associated with the susceptibility to and the survival in chronic lymphocytic leukemia and could also serve as an auxiliary index.
P2860
Q21559659-DE7B11EF-3DC1-4976-BE75-D4406CFC38C1Q24310378-1AC215FD-3DBB-4B99-908D-F66FEEAB6EC2Q33746931-704E390E-A3A5-40DD-8E0F-82945F4A26EBQ36812745-C51BC41E-EA1F-458C-A738-DFB06B6DF333Q36968117-45BBDACE-D797-4CB8-93B2-DDBF245DD6D0Q38610703-DF7239EC-E124-4EF5-847F-00B469D605A6Q39625449-8109AC61-B946-40AF-B14E-8DD622EE703DQ40112081-530CD828-4877-471E-B842-EABB4543C486Q40608568-A2116E8A-11B8-452A-A4AB-6FE1CAF911C3Q41888239-9A9DFB6B-91F0-4DD7-8B2E-98CF5DA086CBQ42621345-914BB4B1-CAE3-4596-B005-C6D210590256Q47163051-12C3334D-40D7-4DF3-A485-85C653A98B2CQ53574392-9154A2EE-AA38-404B-B704-BC20585C5B2EQ55059774-36949FCE-75B9-49EA-A26C-D11587F3C988
P2860
Oncogenic potential of a dominant negative mutant of interferon regulatory factor 3.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Oncogenic potential of a dominant negative mutant of interferon regulatory factor 3.
@en
Oncogenic potential of a dominant negative mutant of interferon regulatory factor 3.
@nl
type
label
Oncogenic potential of a dominant negative mutant of interferon regulatory factor 3.
@en
Oncogenic potential of a dominant negative mutant of interferon regulatory factor 3.
@nl
prefLabel
Oncogenic potential of a dominant negative mutant of interferon regulatory factor 3.
@en
Oncogenic potential of a dominant negative mutant of interferon regulatory factor 3.
@nl
P2093
P2860
P356
P1476
Oncogenic potential of a dominant negative mutant of interferon regulatory factor 3.
@en
P2093
Cheolho Chung
Han-Woong Lee
Jeongbin Yim
Kyoung-Hu Lee
Seungwoo Chang
Tae Kook Kim
Tae Young Kim
P2860
P304
15272-15278
P356
10.1074/JBC.M205792200
P407
P577
2003-02-10T00:00:00Z